Please login to the form below

Not currently logged in

David Theil joins Noxilizer as chief financial officer

He also takes up the role of senior vice president

US-based biotech Noxilizer has appointed David Theil as its new chief financial officer and senior vice president.

Theil has over 25 years of experience in financial, administrative and operational management, specialising in start-up and middle market life sciences companies.

Before joining the biotechnology firm, Theil held various senior management positions at IGEN International, Speciality Pharmaceuticals and Supernus Pharmaceuticals.

He has also served as manager of emerging business markets group for Deloitte & Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

Lawrence Bruder, Noxilizer's president and chief executive officer, said: “David brings experience that is critical to Noxilizer at this stage of the company.

“He has worked in growing companies and understands the opportunities and challenges.”

28th January 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...